bazedoxifene has been researched along with madindoline a in 1 studies
| Studies (bazedoxifene) | Trials (bazedoxifene) | Recent Studies (post-2010) (bazedoxifene) | Studies (madindoline a) | Trials (madindoline a) | Recent Studies (post-2010) (madindoline a) |
|---|---|---|---|---|---|
| 307 | 69 | 249 | 15 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jou, D; Kumari, V; Li, C; Li, H; Lin, J; Lin, L; Xiao, H | 1 |
1 other study(ies) available for bazedoxifene and madindoline a
| Article | Year |
|---|---|
Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cytokine Receptor gp130; Drug Design; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Indoles; Interleukin-6; Ligands; Molecular Docking Simulation; Phosphorylation; Protein Interaction Domains and Motifs; Protein Multimerization; Raloxifene Hydrochloride; Signal Transduction; STAT3 Transcription Factor | 2014 |